Trifluperidol

Trifluperidol

SCHEMBL13724801

CC1CCN(CCCC(=O)c2ccc(F)cc2)CC1.O=C(CCCN1CCC(O)(c2cccc(C(F)(F)F)c2)CC1)c1ccc(F)cc1

nearest known ligand 0.86

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 3/20 0.86
▸ CYP2D6 P10635 3/20 0.86
▸ ABCB11 O95342 2/20 0.86
▸ TSHR P16473 2/20 0.86
▸ THPO P40225 2/20 0.86
▸ MTOR P42345 2/20 0.86
▸ EBP Q15125 2/20 0.86
▸ SIGMAR1 Q99720 2/20 0.86
▸ TP53 P04637 1/20 0.86
▸ PKM P14618 1/20 0.86
▸ MAPK1 P28482 1/20 0.86
▸ PMP22 Q01453 2/20 0.84
▸ KDM4E B2RXH2 1/20 0.84
▸ SMN1; SMN2 Q16637 1/20 0.84
▸ DRD2 P14416 12/20 0.67
▸ HTR1A P08908 3/20 0.63
▸ ADRA2A P08913 3/20 0.63
▸ ADRA1A P35348 3/20 0.63
▸ OPRM1 P35372 3/20 0.63
▸ DRD3 P35462 3/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluperidol SCHEMBL120862 0.93 CYP3A4 (1.00) CYP3A4CYP2D6ABCB11TSHRTHPO
Trifluperidol SCHEMBL29710906 0.93 CYP3A4 (1.00) CYP3A4CYP2D6ABCB11TSHRTHPO
Trifluperidol SCHEMBL14973483 0.92 PMP22 (1.00) CYP3A4CYP2D6ABCB11TSHRTHPO
Trifluperidol SCHEMBL316725 0.92 PMP22 (1.00) CYP3A4CYP2D6ABCB11TSHRTHPO
Trifluperidol SCHEMBL28086762 0.87 ABCB11 (0.88) CYP3A4CYP2D6ABCB11TSHRTHPO
Trifluperidol SCHEMBL5490310 0.86 CYP3A4 (0.83) CYP3A4CYP2D6ABCB11TSHRTHPO
SCHEMBL9053345 0.85 ABCB11 (0.85) CYP3A4CYP2D6ABCB11TSHRTHPO
SCHEMBL11373842 0.83 ABCB11 (0.78) CYP3A4CYP2D6ABCB11TSHRTHPO
Trifluperidol SCHEMBL20606534 0.82 DRD2 (0.71) CYP3A4CYP2D6ABCB11TSHRTHPO
Trifluperidol SCHEMBL5560653 0.82 CYP2D6 (0.72) CYP3A4CYP2D6ABCB11TSHRTHPO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103717597-B Heterocyclic compounds as kinase inhibitors 原真股份有限公司 2017-07-04 — — CN disclosed
CN-103492389-B Pyrazolo [4,3-d] pyrimidine as inhibitors of kinases 原真股份有限公司 2016-09-14 — — CN disclosed
EP-2699579-A1 PYRAZOLO [4, 3-D]PYRIMIDINES USEFUL AS KINASE INHIBITORS Origenis GmbH (DE) 2014-02-26 — — EP disclosed
EP-2699572-A1 HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS Origenis GmbH (DE) 2014-02-26 — — EP disclosed
WO-2012143144-A1 PYRAZOLO [4, 3-D] PYRIMIDINES USEFUL AS KINASE INHIBITORS ORIGENIS GMBH (DE) 2012-10-26 — — WO disclosed
WO-2012143143-A1 HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS ORIGENIS GMBH (DE) 2012-10-26 — — WO disclosed
Send feedback